Presence of contractile endothelin-A and dilatory endothelin-B receptors in human cerebral arteries

Neurosurgery

Volumn 40, Issue 2, 1997, Pages 346-353

  Nilsson, Torun ^a   Cantera, Leonor ^a   Adner, Mikael ^a   Edvinsson, Lars ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bosentan; Cerebral artery; ET(A) receptor; ET(B) receptor; FR139317; Reverse transcriptase polymerase chain reaction; Sarafotoxin 6c

Indexed keywords

2 [[2 [[2 [[(HEXAHYDRO 1H AZEPIN 1 YL)CARBONYL]AMINO] 4 METHYLPENTANOYL]AMINO] 3 (1 METHYL 1H INDOL 3 YL)PROPIONYL]AMINO] 3 (2 PYRIDYL)PROPIONIC ACID; BOSENTAN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; RECEPTOR SUBTYPE; SARAFOTOXIN S6C;

ARTERY CONSTRICTION; ARTERY ENDOTHELIUM; ARTICLE; BRAIN ARTERY; ELECTROPHORESIS; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CEREBRAL ARTERIES; CULTURE TECHNIQUES; GENE EXPRESSION; HUMANS; POLYMERASE CHAIN REACTION; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN; REFERENCE VALUES; VASCULAR RESISTANCE;

EID: 0031033313     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199702000-00023     Document Type: Article

References (37)

1. Adner M, Jansen I, Edvinsson L: Endothelin-A receptors mediate contraction in human cerebral, meningeal and temporal arteries. J Auton Nerv Syst 49:117-121, 1994.
2. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S: Cloning and expressing of a cDNA encoding an endothelin receptor. Nature 348:730-732, 1990.
3. Arai H, Nakao K, Takaya K, Hosoda K, Ogawa Y, Nakanishi S, Imura H: The human endothelin-B receptor gene. J Biol Chem 268:3463-3470, 1993.
4. Asano T, Ikegaki I, Suzuki S, Stoh S, Shibuya M: Endothelin and the production of cerebral vasospasm in dogs. Biochem Biophys Res Commun 159:1345-1351, 1989.
5. Bax WA, Saxena PR: The current endothelin classification: Time for reconsideration? Trends Pharmacol Sci 15:379-386, 1994.
6. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987.
7. A receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injection. Life Sci 52:825-834, 1993.
8. Clozel M, Breu V, Burri K, Cassai J-M, Fischli W, Gray GA, Hirth G, Löffler B-M, Muller M, Neidhart W, Ramuz H: Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature 365:759-761, 1993.
9. Clozel M, Breu V, Gray GA, Kalina B, Löffler B-M, Burri K, Cassal J-M, Hirth G, Muller M, Neidhart W, Ramuz H: Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J Pharmacol Exp 270:228-235, 1994.
10. B receptor mediates both vasodilation and vasoconstriction in vivo. Biochem Biophys Res Commun 186:867-873, 1992.
11. A sub-type. Br J Pharmacol 114: 1110-1116, 1995.
12. De Nucci G, Thomas R, D'Orleans-Juste P, Antunes E, Walder C, Warner TD, Vane JR: Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci U S A 85:9797-9800, 1988.
13. B-receptor stimulation on arterial, venous and capillary functions in cat skeletal muscle. Br J Pharmacol 112:887-894, 1994.
14. Foley PL, Caner HH, Kassell NF, Lee KS: Reversal of subarachnoid hemorrhage-induced vasoconstriction with an endothelin receptor antagonist. Neurosurgery 34:108-113, 1994.
15. Hardebo JE, Kåhrström J, Owman C, Salford LG: Endothelin is a potent constrictor of human intracranial arteries and veins. Blood Vessels 26:249-253, 1989.
16. Hosoda K, Nakao K, Tamura N, Arai H, Ogawa Y, Suga S-I, Nakanishi S, Imura H: Organization, structure, chromosomal assignment, and expression of the gene encoding the human endothelin-A receptor. J Biol Chem 267:18797-18804, 1992.
17. Högestätt ED, Andersson K-E, Edvinsson L: Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels. Acta Physiol Scand 117:49-61, 1983.
18. Kobayashi H, Hayashi M, Kobayashi S, Kabuto M, Handa Y, Kawano H, Ide H: Cerebral vasospasm and vasoconstriction caused by endothelin. Neurosurgery 28:673-679, 1991.
19. Lüscher TF: Do we need endothelin antagonists? Cardiovasc Res 27:2089-2093, 1993.
20. Masaoka H, Suzuki R, Hirata Y, Emori T, Marumo F, Hirakawa K: Raised plasma endothelin in aneurysmal subarachnoid hemorrhage. Lancet 2:1402, 1989 (letter).
21. Matsurama Y, Ikegawa R, Suzuki Y, Takoaka M, Uchida T, Kido H, Shinyama H, Hayashi K, Watanabe M, Morimoto S: Phosphoramidon prevents cerebral vasospasm following subarachnoid hemorrhage in dogs: The relationship to endothelin-1 levels in the cerebrospinal fluid. Life Sci 49:841-848, 1991.
22. A receptor antagonist, FR139317, ameliorates cerebral vasospasm in dogs. Life Sci 52:1869-1874, 1993.
23. Ohlstein EH, Storer BL: Oxyhemoglobin stimulation of endothelin production in cultured endothelial cells. J Neurosurg 77:274-278, 1992.
24. B, receptor subtypes across the menstrual cycle. J Clin Endocrinol Metab 75:1545-1549, 1992.
25. Patel TR, McAuley MA, McCulloch J: Effects on feline pial arterioles in situ of bosentan, a non-peptide endothelin receptor antagonist. Eur J Pharmacol 260:65-71, 1994.
26. Roux S, Löffler B-M, Gray GA, Sprecher U, Clozel M, Clozel J-P: The role of endothelin in experimental cerebral vasospasm. Neurosurgery 37:78-86, 1995.
27. Sakurai T, Yanagisawa M, Masaki T: Molecular characterization of endothelin receptors. Trends Pharmacol Sci 13:103-108, 1992.
28. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T: Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348:732-735, 1990.
29. B receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 89:1203-1208, 1994.
30. Shigeno T, Clozel M, Sakai S, Saito A, Goto K: The effect of bosentan, a new potent endothelin receptor antagonist, on pathogenesis of cerebral vasospasm. Neurosurgery 37:87-91, 1995.
31. Shigeno T, Mima T, Yanagisawa M, Saito A, Goto K, Yamashita K, Takenouchi T, Matsuura N, Yamasaki Y, Yamada K, Masaki T, Takakura K: Prevention of cerebral vasospasm by actinomycin D. J Neurosurg 74:940-943, 1991.
32. A receptor antagonist. J Pharmacol Exp Ther 264:1040-1046, 1993.
33. Suzuki H, Sato S, Suzuki Y, Takekoshi K, Ishihara N, Shimoda S: Increased endothelin concentration in CSF from patients with subarachnoid hemorrhage. Acta Neurol Scand 81:553-554, 1990.
34. Tallarida RJ, Cowan A, Adler MW: pA2 and receptor differentiation: A statistical analysis of competitive antagonism. Life Sci 25:637-654, 1979.
35. Willette RN, Zhang H, Mitchell MP, Sauermelch CF, Ohlstein EH, Sulpizio AC: Nonpeptide Y antagonist: Cerebrovascular characterization and effects on delayed cerebral vasospasm. Stroke 25:2450-2456, 1994.
36. Williams DL, Jones KL, Pettibone DJ, Lis EV, Clineschmidt BV: Sarafotoxin 6c: An agonist which distinguishes between endothelin receptor subtypes. Biochem Biophys Res Commun 175:556-561, 1991.
37. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T: Novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988.